Literature DB >> 8541869

Dystrophin-associated proteins in muscular dystrophy.

E Ozawa1, M Yoshida, A Suzuki, Y Mizuno, Y Hagiwara, S Noguchi.   

Abstract

Dystrophin-associated proteins (DAPs) are classified into a few groups, namely, those comprising of dystroglycan complex, sarcoglycan complex, syntrophin complex and others. Subsarcolemmal actin filaments are connected to laminin in the basement membrane through dystrophin and the dystroglycan complex. This system may function to protect muscle fibers from mechanical damage. Furthermore, the sarcoglycan complex is associated with the system. Defects in the components of the protection system or the sarcoglycan complex or both are characteristically found in various muscular dystrophies. The roles of the syntrophin complex are meagerly understood. In this review, the possible roles of laminin, DAPs and dystrophin in each dystrophy are explained.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8541869     DOI: 10.1093/hmg/4.suppl_1.1711

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  35 in total

1.  Extrasynaptic location of laminin beta 2 chain in developing and adult human skeletal muscle.

Authors:  U M Wewer; L E Thornell; F Loechel; X Zhang; M E Durkin; S Amano; R E Burgeson; E Engvall; R Albrechtsen; I Virtanen
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  A new method of genotyping MDX4CV mice by PCR-RFLP analysis.

Authors:  Elisia D Tichy; Foteini Mourkioti
Journal:  Muscle Nerve       Date:  2017-03-21       Impact factor: 3.217

3.  Differential expression of dystrophin isoforms and utrophin during dibutyryl-cAMP-induced morphological differentiation of rat brain astrocytes.

Authors:  M Imamura; E Ozawa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 4.  [Genetics of dilated cardiomyopathy].

Authors:  L Thierfelder
Journal:  Med Klin (Munich)       Date:  1998-04-15

5.  Isolation and characterization of the complete mouse emerin gene.

Authors:  K Small; M Wagener; S T Warren
Journal:  Mamm Genome       Date:  1997-05       Impact factor: 2.957

Review 6.  Creatine kinase, cell membrane and Duchenne muscular dystrophy.

Authors:  E Ozawa; Y Hagiwara; M Yoshida
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

7.  Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23.

Authors:  D N Messina; M C Speer; M A Pericak-Vance; E M McNally
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

8.  Molecular and functional analysis of the utrophin promoter.

Authors:  C L Dennis; J M Tinsley; A E Deconinck; K E Davies
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

Review 9.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

10.  Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting.

Authors:  Kristy Swiderski; Scott A Shaffer; Byron Gallis; Guy L Odom; Andrea L Arnett; J Scott Edgar; Dale M Baum; Annabel Chee; Timur Naim; Paul Gregorevic; Kate T Murphy; James Moody; David R Goodlett; Gordon S Lynch; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2014-07-31       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.